Page 1 of Clinical Trials for Mitoxantrone, 210 Total Matches
- 1Active, not recruitingLast Updated: April 6, 2010Condition(s): Androgen-independent Prostate Cancer
- 2SuspendedLast Updated: July 19, 2011Condition(s): Leukemia
- 3CompletedLast Updated: October 18, 2010Condition(s): Cancer, Prostate
- 4Active, not recruitingLast Updated: September 1, 2011Condition(s): Prostate Cancer
- 5RecruitingLast Updated: April 28, 2011Condition(s): Acute Myeloid Leukemia
- 6RecruitingLast Updated: April 25, 2012Condition(s): Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia
- 7RecruitingLast Updated: January 24, 2012Condition(s): Leukemia; Acute Lymphoblastic Leukemia
- 8Active, not recruitingLast Updated: September 2, 2011Condition(s): Chronic Lymphocytic Leukemia
- 9CompletedLast Updated: April 13, 2011Condition(s): Relapsing Remitting Multiple Sclerosis
- 10TerminatedLast Updated: January 31, 2012Condition(s): Leukemia
- 11Active, not recruitingLast Updated: January 4, 2012Condition(s): Follicular Lymphoma
- 12RecruitingBortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaLast Updated: April 27, 2012Condition(s): Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia
- 13Active, not recruitingLast Updated: January 30, 2012Condition(s): Lymphoma
- 14CompletedLast Updated: June 23, 2005Condition(s): Lymphoma, Non-Hodgkin; HIV Infections
- 15Not yet recruitingLast Updated: May 7, 2012Condition(s): Metastatic Castration-resistant Prostate Cancer
- 16Active, not recruitingLast Updated: August 16, 2011Condition(s): Multiple Sclerosis
- 17TerminatedLast Updated: August 21, 2008Condition(s): Prostatic Neoplasms
- 18TerminatedLast Updated: August 5, 2011Condition(s): Leukemia
- 19CompletedLast Updated: August 5, 2011Condition(s): Leukemia
- 20TerminatedLast Updated: September 13, 2011Condition(s): Metastatic Prostate Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Mitoxantrone
